Propafenone for the Treatment of Refractory Complex Ventricular Ectopic Activity
- 1 February 1986
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 61 (2) , 98-103
- https://doi.org/10.1016/s0025-6196(12)65194-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Antiarrhythmic and electrophysiologic effects of oral propafenoneThe American Journal of Cardiology, 1984
- Effect of propafenone on left ventricular ejection fractionThe American Journal of Cardiology, 1984
- Clinical pharmacology of propafenone: Pharmacokinetics, metabolism and concentration-response relationsThe American Journal of Cardiology, 1984
- Clinical Pharmacokinetics of the Newer Antiarrhythmic AgentsClinical Pharmacokinetics, 1984
- A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexesThe American Journal of Cardiology, 1983
- Clinical pharmacology of propafenone.Circulation, 1983
- Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugsThe American Journal of Cardiology, 1982
- Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.Circulation, 1982
- Electrophysiological and Antiarrhythmic Properties of Propafenon in Isolated Cardiac PreparationsJournal of Cardiovascular Pharmacology, 1981
- Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency.Circulation, 1978